Cargando…
Functional and pharmacological evaluation of a novel SCN2A variant linked to early‐onset epilepsy
OBJECTIVE: We identified a novel de novo SCN2A variant (M1879T) associated with infantile‐onset epilepsy that responded dramatically to sodium channel blocker antiepileptic drugs. We analyzed the functional and pharmacological consequences of this variant to establish pathogenicity, and to correlate...
Autores principales: | Adney, Scott K., Millichap, John J., DeKeyser, Jean‐Marc, Abramova, Tatiana, Thompson, Christopher H., George, Alfred L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480906/ https://www.ncbi.nlm.nih.gov/pubmed/32750235 http://dx.doi.org/10.1002/acn3.51105 |
Ejemplares similares
-
Epilepsy-associated SCN2A (Na(V)1.2) Variants Exhibit Diverse and Complex Functional Properties
por: Thompson, Christopher H., et al.
Publicado: (2023) -
Epilepsy-associated SCN2A (Na(V)1.2) variants exhibit diverse and complex functional properties
por: Thompson, Christopher H., et al.
Publicado: (2023) -
Spectrum of SCN8A-Related Epilepsy
por: Morgan, Lindsey A., et al.
Publicado: (2015) -
Alternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants
por: Thompson, Christopher H., et al.
Publicado: (2020) -
Functional consequences of a KCNT1 variant associated with status dystonicus and early‐onset infantile encephalopathy
por: Gertler, Tracy S., et al.
Publicado: (2019)